Genovis signs distribution deal with Nordic Biolabs

Genovis began selling its products in September 2007. The aim is to engage strategic distributors with strong customer relations in 2008 on Genovis’ most crucial markets, including the Nordic domestic market, but primarily the US and rapidly growing Asian markets.

“We’re glad Nordic Biolabs, with their knowledgeable product specialists and extensive sales experience with Genovis’ target audience, chose to distribute our products,” says Sarah Fredriksson, CEO at Genovis. “This partnership can also strengthen Genovis internally as far as sales issues go, which is something we can also use on other international markets.”

Nordic Biolabs, with budgeted sales of SEK 60 million in 2008, is a leading supplier of products for medical research, diagnostics, microbiology, and transfusion drugs, and represents more than 40 strong suppliers and brands. The company is based in Täby, north of Stockholm, and has seven sales representatives in Stockholm Lund, and Copenhagen. Nordic Biolab’s customers are labs in hospitals, universities, and pharmaceutical and biotech industries.

“Genovis has an exciting product portfolio that is really at the forefront of one of the hottest research areas,” says Thomas Busch, CEO at Nordic Biolabs. “We hope this partnership will strengthen our offering as well as contribute to increased sales for Genovis.”

Genovis currently markets 12 products in two different application areas: biomolecule delivery and imaging, and antibody tools. Genovis’ marketing strategy for providing customers with effective service and support is to choose partners with strong customer relations on different geographic markets within the product groups with which Genovis works.